Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Generics
 More »

  • Generics Asia Summit
    Singapore SINGAPORE www.generics-asia.com
    11-11-2013
  • China's Challenges Stretch Beyond the GSK Scandal
    ... of managing costs (though use of generics and other price control mechanisms) and supporting research-oriented industries that want patent protection and high returns," Dr. ...
    7-31-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    ... projects and higher-return investments in generics, and pursuing buyers for its HealthTronics urological business and branded pharmaceutical early-stage discovery platform. ...
    7-11-2013
  • In $1B Deal, Merck Sells API Business, 11-Drug Portfolio
    says will broaden its offerings beyond generics and boost its presence in Asia and Latin ... take place December 31. The buyer, Dutch generics giant Aspen Group, looks to broaden ...
    6-27-2013
  • Cancer's Bitter Medicine
    Free-market economics has also failed to deliver savings from generics, Dr. Kantarjian added. Prices have dropped so steeply, many companies fled the U.S. Last year in the Journal ...
    6-15-2013
  • Valeant Acquiring Bausch + Lomb for $8.7B
    Since then, Valeant has positioned itself as a specialty maker of branded pharmaceuticals, branded generics, and over-the-counter products, with a partial focus on dermatology. ...
    5-28-2013
  • Cancer's Bitter Medicine
    Free-market economics has also failed to deliver savings from generics, Dr. Kantarjian added. Prices have dropped so steeply, many companies fled the U.S. Last year in the Journal ...
    5-21-2013
  • Actavis Acquiring Warner Chilcott for $8.5B
    ... and faces stepped-up competition from generics in the U.S. Actonel revenue fell about 33% last year, to $519 million, and another 24% during the first quarter, to $111 million. ...
    5-20-2013
  • Report: Orphan Drugs Cheaper to Bring to Market, Offer Better...
    Worldwide orphan drug sales are slated to reach $127 billion by 2018, according to an EvaluatePharma® report released today. Excluding generics, orphan drugs are expected to make ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    FDA does since patents for 12 blockbuster biologic compounds generating a combined $67 billion in sales will expire by 2020, according to the Generics and Biosimilars Initiative. ...
    4-22-2013
  • Poland Invests in Biotech Infrastructure
    Piotr Zien, Ph.D., head of science projects at Polpharma Biologics, states: "Biologics are new for Polpharma as the company has relied on producing small molecule-based generics in ...
    4-15-2013
  • Obama Budget: More NIH Grants, Higher FDA User Fees
    ... But in his FY 2014 budget proposal, Obama called instead for $760 million in prescription-drug user fees, up 5.5% from FDASIA; $305.996 million for generics user fees, up almost $7 ...
    4-11-2013
  • Top 20 Biopharma R&D Spenders
    Of the seven companies that spent more on R&D in proportion to their sales last year compared with 2008, nearly all were either generics giants eager to develop portfolios of ...
    4-1-2013
  • Actavis Eyes 2016 Generic Crestor Launch After Settling Patent...
    Actavis, the world's third-largest generics prescription drug manufacturer, said it will ... in the heartburn drug Nexium IP. Generics giant undecided on launch of ...
    3-25-2013
  • AstraZeneca Idling Another 2,300; Unveils Comeback Strategy
    ... The higher risk, Fitch said, stems from less stable revenue streams in pharma vs. generics or OTC. "As opposed to its more diversified European peers GlaxoSmithKline, Bayer, ...
    3-21-2013
  • More »

    Journal Articles

  • Natural Corneal Cell-based Microenvironment as Prerequisite for...
    Simon Schulz, David Beck, Dougal Laird, Thorsten Steinberg, Pascal Tomakidi, Thomas Reinhard, Philipp Eberwein
    Tissue Engineering, Part C: Methods
    Such equivalents will be promising tools in ophthalmology, e.g. for mechanistic studies in basic research and/or testing of generics or preclinical validation of innovative ...
  • Introduction to the Canadian Scientific Advisory Committee on...
    Irvin Mayers
    Journal of Aerosol Medicine and Pulmonary Drug Delivery
    Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: In Vivo Evaluation For Clinical Testing in COPD and Asthma Therapy Using Generics ...
  • Quality and Behavior of Glimepiride Generics Versus Amaryl Under...
    Giuseppe Attorrese, Massimo Massi-Benedetti
    Diabetes Technology & Therapeutics
    Quality and Behavior of Glimepiride Generics Versus Amaryl Under Stressed Conditions Diabetes Technology & Therapeutics
  • The US and EU Regulatory Landscapes for Locally Acting Generic...
    Anders Fuglsang
    Journal of Aerosol Medicine and Pulmonary Drug Delivery
    current EU law does not provide for submission of such products as generics due to the definition of bioequivalence and bioavailability, instead they must be submitted as hybrids. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll